TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.3. Research Objective
2.4. Assumptions
2.5. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Technique
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porterโs Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Impact on Supply Chain
6. GLOBAL PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES
6.1. Overview
6.2. Tele Consultation
6.3. In-Person Care
6.4. Vaccine Scheduling
6.5. Medicine Delivery
7. GLOBAL PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE
7.1. Overview
7.2. Migraine
7.3. Diabetes
7.4. Obesity
7.5. Pneumococcal pneumonia
7.6. Flu
7.7. Others
8. GLOBAL PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE
8.1. Overview
8.2. Disease Treatment
8.3. Disease Prevention
9. GLOBAL PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East and Africa and Africa
9.4.2. South America
10. COMPANY LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Pharmaceutical Digital Platform Market
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Pharmaceutical Digital Platform Market
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2023
10.8.2. Major Players R&D Expenditure. 2023
11. COMPANY PROFILES
11.1. AstraZeneca (UK)
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Pfizer, Inc. (US)
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. Eli Lilly and Company (US)
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. F. Hoffmann-La Roche Ltd. (Switzerland)
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. Bayer AG (Germany)
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Sanofi (France)
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Astellas Pharma Inc. (Japan)
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. Boehringer Ingelheim International GmbH (Germany)
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Gilead Sciences, Inc. (US)
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Bristol-Myers Squibb Company (US)
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL PHARMACEUTICAL DIGITAL PLATFORM MARKET, SYNOPSIS, 2019โ2032
TABLE 2 GLOBAL PHARMACEUTICAL DIGITAL PLATFORM MARKET, ESTIMATES & FORECAST, 2019โ2032 (USD BILLION)
TABLE 3 GLOBAL PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 4 GLOBAL PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 5 GLOBAL PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
TABLE 6 NORTH AMERICA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 7 NORTH AMERICA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 8 NORTH AMERICA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
TABLE 9 US: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 10 US: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 11 US: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
TABLE 12 CANADA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 13 CANADA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 14 CANADA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
TABLE 1 EUROPE: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 2 EUROPE: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 3 EUROPE: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
TABLE 4 GERMANY: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 5 GERMANY: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 6 GERMANY: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
TABLE 7 FRANCE: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 8 FRANCE: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 9 FRANCE: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
TABLE 10 ITALY: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 11 ITALY: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 12 ITALY: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
TABLE 13 SPAIN: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 14 SPAIN: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 15 SPAIN: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
TABLE 16 UK: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 17 UK: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 18 UK: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
TABLE 19 REST OF EUROPE: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 20 REST OF EUROPE: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 21 REST OF EUROPE: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
TABLE 22 ASIA-PACIFIC: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 23 ASIA-PACIFIC: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 24 ASIA-PACIFIC: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
TABLE 25 JAPAN: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 26 JAPAN: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 27 JAPAN: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
TABLE 28 CHINA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 29 CHINA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 30 CHINA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
TABLE 31 INDIA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 32 INDIA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 33 INDIA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
TABLE 34 AUSTRALIA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 35 AUSTRALIA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 36 AUSTRALIA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
TABLE 37 SOUTH KOREA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 38 SOUTH KOREA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 39 SOUTH KOREA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
TABLE 40 REST OF ASIA-PACIFIC: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 41 REST OF ASIA-PACIFIC: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 42 REST OF ASIA-PACIFIC: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
TABLE 43 REST OF THE WORLD: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 44 REST OF THE WORLD: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 45 REST OF THE WORLD: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
TABLE 46 MIDDLE EAST AND AFRICA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 47 MIDDLE EAST AND AFRICA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 48 MIDDLE EAST AND AFRICA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
TABLE 49 SOUTH AMERICA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY SERVICES, 2019โ2032 (USD BILLION)
TABLE 50 SOUTH AMERICA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY DISEASE, 2019โ2032 (USD BILLION)
TABLE 51 SOUTH AMERICA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, BY END USE, 2019โ2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PHARMACEUTICAL DIGITAL PLATFORM MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PHARMACEUTICAL DIGITAL PLATFORM MARKET
FIGURE 4 GLOBAL PHARMACEUTICAL DIGITAL PLATFORM MARKET, SHARE (%), BY SERVICES, 2023
FIGURE 5 GLOBAL PHARMACEUTICAL DIGITAL PLATFORM MARKET, SHARE (%), BY DISEASE, 2023
FIGURE 6 GLOBAL PHARMACEUTICAL DIGITAL PLATFORM MARKET, SHARE (%), BY END USE, 2023
FIGURE 7 GLOBAL PHARMACEUTICAL DIGITAL PLATFORM MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 NORTH AMERICA: PHARMACEUTICAL DIGITAL PLATFORM MARKET, SHARE (%), BY COUNTRY, 2023
FIGURE 9 EUROPE: PHARMACEUTICAL DIGITAL PLATFORM MARKET, SHARE (%), BY COUNTRY, 2023
FIGURE 10 ASIA-PACIFIC: PHARMACEUTICAL DIGITAL PLATFORM MARKET, SHARE (%), BY COUNTRY, 2023
FIGURE 11 REST OF THE WORLD: PHARMACEUTICAL DIGITAL PLATFORM MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 GLOBAL PHARMACEUTICAL DIGITAL PLATFORM MARKET: COMPANY SHARE ANALYSIS (%), 2023
FIGURE 13 ASTRAZENECA (UK): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 ASTRAZENECA (UK): SWOT ANALYSIS
FIGURE 15 PFIZER, INC. (US): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 PFIZER, INC. (US): SWOT ANALYSIS
FIGURE 17 ELI LILLY AND COMPANY.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 ELI LILLY AND COMPANY.: SWOT ANALYSIS
FIGURE 19 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS
FIGURE 21 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 BAYER AG: SWOT ANALYSIS
FIGURE 23 SANOFI: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 SANOFI: SWOT ANALYSIS
FIGURE 25 ASTELLAS PHARMA INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 ASTELLAS PHARMA INC: SWOT ANALYSIS
FIGURE 27 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: SWOT ANALYSIS
FIGURE 29 GILEAD SCIENCES, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 GILEAD SCIENCES, INC: SWOT ANALYSIS
FIGURE 31 BRISTOL-MYERS SQUIBB COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 BRISTOL-MYERS SQUIBB COMPANY: SWOT ANALYSIS